痰热清注射液治疗COPD合并呼吸衰竭的临床疗效观察

Clinical Observation of Tanreqing Injection in the Treatment of COPD Combined with Respiratory Failure

目的:观察痰热清注射液治疗慢性阻塞性肺疾病(COPD)合并呼吸衰竭的临床疗效。方法:将COPD合并呼吸衰竭患者60例随机平均分为治疗组和对照组,其中对照组采用常规治疗法,治疗组在对照组基础上加用痰热清注射液30mL静脉滴注,1次.d-1,疗程7～10d。结果:治疗组的总有效率为86.57%,显著高于73.33%的对照组(P<0.05);与对照组比较,治疗组可显著改善缺氧,降低二氧化碳分压(P<0.05)。结论:痰热清注射液治疗COPD合并呼吸衰竭疗效确切。

OBJECTIVE： To observe the clinical efficacy of Tanreqing injection in treating COPD combined with respira- tory failure. METHODS： A total of 60 patients with COPD combined with respiratory failure were enrolled, 30（control group） were randomly assigned to receive routine therapy, another 30 （trial group） to receive routine therapy plus Tanreqing injection （30mL） by intravenous drip q.d for 7-10 days. RESULTS： The total effective rate in the trial group （86.57%） was significantly higher than in the control group（73.33% ）（P 〈 0.05） .And compared with control group, hypoxia was significantly improved and carbon dioxide partial pressure was significantly decreased in the trial group（P 〈 0.05）.CONCLUSION： Tanreqing injection has been confirmed to be effective in the treatment of COPD combined with respiratory failure.